Skip to main content
Erschienen in: International Ophthalmology 6/2016

18.02.2016 | Original Paper

Comparability of retinal thickness measurements using different scanning protocols on spectral-domain optical coherence tomography

verfasst von: Milton C. Chew, Louis W. Lim, Eujin Tan, Colin S. Tan

Erschienen in: International Ophthalmology | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Retinal thickness measurements obtained using optical coherence tomography (OCT) play an essential role both in multi-center clinical trials and in normal clinical practice. Different scanning protocols are available on most OCT devices, and it is important to ascertain whether the retinal thickness measurements obtained from these are comparable. This study aimed to compare retinal thickness measurements between raster and radial scanning protocols using spectral-domain OCT (SD-OCT). In a prospective study, 32 healthy subjects were scanned sequentially using raster and radial protocols from a SD-OCT device. For both the raster and radial OCT scans, retinal thicknesses were measured manually subfoveally and at 12 other points at 0.5 mm intervals temporally and nasally on the horizontal OCT B-scan passing through the fovea. The retinal thickness measurements were compared using intraclass correlation (ICC) and Bland–Altman plots. Subfoveal retinal thickness was 227.0 µm when measured on the raster scan and 229.2 µm on the radial scan, with a mean difference of 2.2 µm (P = 0.141).The ICC for agreement was 0.889 (95 % confidence interval 0.818–0.933). Similar results were observed for retinal thickness measurements at all other points, with mean differences ranging from −3.37 to 2.59 µm, and ICC values ranging from 0.837 to 0.972. The retinal thickness measurements obtained by the raster and radial scans of the same SD-OCT device are comparable, with differences of less than 4 µm. This is of relevance when measurements made using different OCT scan protocols are compared.
Literatur
1.
Zurück zum Zitat Tan CS, Chew MC, Lim TH (2009) Comparison of foveal-sparing with foveal-involving photodynamic therapy for myopic choroidal neovascularization. Eye (Lond) 28:17–22CrossRef Tan CS, Chew MC, Lim TH (2009) Comparison of foveal-sparing with foveal-involving photodynamic therapy for myopic choroidal neovascularization. Eye (Lond) 28:17–22CrossRef
2.
Zurück zum Zitat Tan CS, Chew MC, Lim KH, Lim TH (2013) Factors affecting visual outcome of myopic choroidal neovascularization treated with verteporfin photodynamic therapy. Int J Ophthalmol 6:327–330PubMedPubMedCentral Tan CS, Chew MC, Lim KH, Lim TH (2013) Factors affecting visual outcome of myopic choroidal neovascularization treated with verteporfin photodynamic therapy. Int J Ophthalmol 6:327–330PubMedPubMedCentral
3.
Zurück zum Zitat Tan CS, Ngo WK, Lim LW, Lim TH (2014) A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes. Br J Ophthalmol 98:1528–1533CrossRefPubMed Tan CS, Ngo WK, Lim LW, Lim TH (2014) A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes. Br J Ophthalmol 98:1528–1533CrossRefPubMed
4.
Zurück zum Zitat Lim TH, Laude A, Tan CS (2010) Polypoidal choroidal vasculopathy: an angiographic discussion. Eye (Lond) 24:483–490CrossRef Lim TH, Laude A, Tan CS (2010) Polypoidal choroidal vasculopathy: an angiographic discussion. Eye (Lond) 24:483–490CrossRef
5.
Zurück zum Zitat Tan CS, Ngo WK, Chen JP, Tan N, Lim TH (2015) EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy. Br J Ophthalmol 99:624–628CrossRefPubMedPubMedCentral Tan CS, Ngo WK, Chen JP, Tan N, Lim TH (2015) EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy. Br J Ophthalmol 99:624–628CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Tan CS, Cheong KX, Lim LW, Li KZ (2014) Topographic variation of choroidal and retinal thicknesses at the macula in healthy adults. Br J Ophthalmol 98:339–344CrossRefPubMed Tan CS, Cheong KX, Lim LW, Li KZ (2014) Topographic variation of choroidal and retinal thicknesses at the macula in healthy adults. Br J Ophthalmol 98:339–344CrossRefPubMed
7.
Zurück zum Zitat Schmidt-Erfurth U, Leitgeb RA, Michels S, Povazay B, Sacu S, Hermann B et al (2005) Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases. Invest Ophthalmol Vis Sci 46:3393–3402CrossRefPubMed Schmidt-Erfurth U, Leitgeb RA, Michels S, Povazay B, Sacu S, Hermann B et al (2005) Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases. Invest Ophthalmol Vis Sci 46:3393–3402CrossRefPubMed
8.
Zurück zum Zitat Singer M, Tan CS, Bell D, Sadda SR (2014) Area of peripheral retinal nonperfusion and treatment response in branch and central retinal vein occlusion. Retina 34:1736–1742CrossRefPubMed Singer M, Tan CS, Bell D, Sadda SR (2014) Area of peripheral retinal nonperfusion and treatment response in branch and central retinal vein occlusion. Retina 34:1736–1742CrossRefPubMed
9.
Zurück zum Zitat Tan CS, Sadda SR, Hariprasad SM (2014) Ultra-widefield retinal imaging in the management of diabetic eye diseases. Ophthalmic Surg Lasers Imaging Retina 45:363–366CrossRefPubMed Tan CS, Sadda SR, Hariprasad SM (2014) Ultra-widefield retinal imaging in the management of diabetic eye diseases. Ophthalmic Surg Lasers Imaging Retina 45:363–366CrossRefPubMed
10.
Zurück zum Zitat Heussen F, Tan CS, Sadda SR (2012) Prevalence of peripheral abnormalities on ultra-widefield greenlight (532 nm) autofluorescence imaging at a tertiary care center. Invest Ophthalmol Vis Sci 53:6526–6531CrossRefPubMedPubMedCentral Heussen F, Tan CS, Sadda SR (2012) Prevalence of peripheral abnormalities on ultra-widefield greenlight (532 nm) autofluorescence imaging at a tertiary care center. Invest Ophthalmol Vis Sci 53:6526–6531CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Tan CS, Heussen F, Sadda S (2013) Peripheral autofluorescence and clinical findings in neovascular and non-neovascular age-related macular degeneration. Ophthalmology 120:1271–1277CrossRefPubMed Tan CS, Heussen F, Sadda S (2013) Peripheral autofluorescence and clinical findings in neovascular and non-neovascular age-related macular degeneration. Ophthalmology 120:1271–1277CrossRefPubMed
12.
Zurück zum Zitat Keane PA, Tan CS, Singer MA, Sadda SR (2014) Role of imaging in the management of macular edema secondary to retina vein occlusion. In: Hariprasad SM (ed) Management of retinal vein occlusion: current concepts. SLACK Inc, Thorofare, pp 79–120 Keane PA, Tan CS, Singer MA, Sadda SR (2014) Role of imaging in the management of macular edema secondary to retina vein occlusion. In: Hariprasad SM (ed) Management of retinal vein occlusion: current concepts. SLACK Inc, Thorofare, pp 79–120
13.
Zurück zum Zitat Tan CS, Ngo WK, Cheong KX (2015) Comparison of choroidal thicknesses using swept source and spectral domain optical coherence tomography in diseased and normal eyes. Br J Ophthalmol 99:354–358CrossRefPubMed Tan CS, Ngo WK, Cheong KX (2015) Comparison of choroidal thicknesses using swept source and spectral domain optical coherence tomography in diseased and normal eyes. Br J Ophthalmol 99:354–358CrossRefPubMed
14.
Zurück zum Zitat Tan CS, Cheong KX (2014) Macular choroidal thicknesses in healthy adults–relationship with ocular and demographic factors. Invest Ophthalmol Vis Sci 55:6452–6458CrossRefPubMed Tan CS, Cheong KX (2014) Macular choroidal thicknesses in healthy adults–relationship with ocular and demographic factors. Invest Ophthalmol Vis Sci 55:6452–6458CrossRefPubMed
15.
Zurück zum Zitat Chen T, Cense B, Pierce M, Nassif N, Park B, Yun S et al (2005) Spectral domain optical coherence tomography: ultra-high speed, ultra-high resolution ophthalmic imaging. Arch Ophthalmol 123:1715–1720CrossRefPubMed Chen T, Cense B, Pierce M, Nassif N, Park B, Yun S et al (2005) Spectral domain optical coherence tomography: ultra-high speed, ultra-high resolution ophthalmic imaging. Arch Ophthalmol 123:1715–1720CrossRefPubMed
16.
Zurück zum Zitat Rajendram R, Fraser-Bell S, Kaines A, Michaelides M, Hamilton RD, Esposti SD et al (2012) A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3. Arch Ophthalmol 130:972–979CrossRefPubMed Rajendram R, Fraser-Bell S, Kaines A, Michaelides M, Hamilton RD, Esposti SD et al (2012) A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3. Arch Ophthalmol 130:972–979CrossRefPubMed
17.
Zurück zum Zitat Do DV, Nguyen QD, Boyer D, Schmidt-Erfurth U, Brown DM, Vitti R et al (2012) One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema. Ophthalmology 119:1658–1665CrossRefPubMed Do DV, Nguyen QD, Boyer D, Schmidt-Erfurth U, Brown DM, Vitti R et al (2012) One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema. Ophthalmology 119:1658–1665CrossRefPubMed
18.
Zurück zum Zitat Taban M, Sharma S, Williams DR, Waheed N, Kaiser PK (2009) Comparing retinal thickness measurements using automated fast macular thickness map versus six-radial line scans with manual measurements. Ophthalmology 116:964–970CrossRefPubMed Taban M, Sharma S, Williams DR, Waheed N, Kaiser PK (2009) Comparing retinal thickness measurements using automated fast macular thickness map versus six-radial line scans with manual measurements. Ophthalmology 116:964–970CrossRefPubMed
19.
Zurück zum Zitat Carpineto P, Nubile M, Toto L, Aharrh Gnama A, Marcucci L, Mastropasqua L et al (2010) Correlation in foveal thickness measurements between spectral-domain and time-domain optical coherence tomography in normal individuals. Eye (Lond) 24:251–258CrossRef Carpineto P, Nubile M, Toto L, Aharrh Gnama A, Marcucci L, Mastropasqua L et al (2010) Correlation in foveal thickness measurements between spectral-domain and time-domain optical coherence tomography in normal individuals. Eye (Lond) 24:251–258CrossRef
20.
Zurück zum Zitat Grover S, Murthy RK, Brar VS, Chalam KV (2010) Comparison of retinal thickness in normal eyes using Stratus and Spectralis optical coherence tomography. Invest Ophthalmol Vis Sci 51:2644–2647CrossRefPubMed Grover S, Murthy RK, Brar VS, Chalam KV (2010) Comparison of retinal thickness in normal eyes using Stratus and Spectralis optical coherence tomography. Invest Ophthalmol Vis Sci 51:2644–2647CrossRefPubMed
21.
Zurück zum Zitat Hee MR, Izatt JA, Swanson EA, Huang D, Schuman JS, Lin CP et al (1995) Optical coherence tomography of the human retina. Arch Ophthalmol 113:325–332CrossRefPubMed Hee MR, Izatt JA, Swanson EA, Huang D, Schuman JS, Lin CP et al (1995) Optical coherence tomography of the human retina. Arch Ophthalmol 113:325–332CrossRefPubMed
22.
Zurück zum Zitat Rahimy E, Rayess N, Maguire JI, Hsu J (2014) Radial versus raster spectral-domain optical coherence tomography scan patterns for detection of macular pathology. Am J Ophthalmol 158:345–353CrossRefPubMed Rahimy E, Rayess N, Maguire JI, Hsu J (2014) Radial versus raster spectral-domain optical coherence tomography scan patterns for detection of macular pathology. Am J Ophthalmol 158:345–353CrossRefPubMed
23.
Zurück zum Zitat Tan CS, Li KZ, Lim TH (2012) A novel technique of adjusting segmentation boundary layers to achieve comparability of retinal thickness and volumes between spectral domain and time domain optical coherence tomography. Invest Ophthalmol Vis Sci 53:5515–5519CrossRefPubMed Tan CS, Li KZ, Lim TH (2012) A novel technique of adjusting segmentation boundary layers to achieve comparability of retinal thickness and volumes between spectral domain and time domain optical coherence tomography. Invest Ophthalmol Vis Sci 53:5515–5519CrossRefPubMed
24.
Zurück zum Zitat Tan CS, Li KZ, Lim TH (2014) Calculating the predicted retinal thickness from spectral domain and time domain optical coherence tomography-comparison of different methods. Graefes Arch Clin Exp Ophthalmol 252:1491–1499CrossRefPubMed Tan CS, Li KZ, Lim TH (2014) Calculating the predicted retinal thickness from spectral domain and time domain optical coherence tomography-comparison of different methods. Graefes Arch Clin Exp Ophthalmol 252:1491–1499CrossRefPubMed
25.
Zurück zum Zitat Murray TG, Tornambe P, Dugel P, Tong KB (2011) Evaluation of economic efficiencies in clinical retina practice: activity-based cost analysis and modeling to determine impacts of changes in patient management. Clin Ophthalmol 5:913–925CrossRefPubMedPubMedCentral Murray TG, Tornambe P, Dugel P, Tong KB (2011) Evaluation of economic efficiencies in clinical retina practice: activity-based cost analysis and modeling to determine impacts of changes in patient management. Clin Ophthalmol 5:913–925CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Lalwani GA, Rosenfeld PJ, Fung AE, Dubovy SR, Michels S, Feuer W et al (2009) A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol 148:43–58CrossRefPubMed Lalwani GA, Rosenfeld PJ, Fung AE, Dubovy SR, Michels S, Feuer W et al (2009) A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol 148:43–58CrossRefPubMed
27.
Zurück zum Zitat Jaissle G, Leitritz M, Gelisken F, Ziemssen F, Bartz-Schmidt K, Szurman P et al (2009) One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 247:27–33CrossRefPubMed Jaissle G, Leitritz M, Gelisken F, Ziemssen F, Bartz-Schmidt K, Szurman P et al (2009) One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 247:27–33CrossRefPubMed
28.
Zurück zum Zitat Shienbaum G, Gupta OP, Fecarotta C, Patel AH, Kaiser RS, Regillo CD et al (2012) Bevacizumab for neovascular age-related macular degeneration using a treat-and-extend regimen: clinical and economic impact. Am J Ophthalmol 153:468–473CrossRefPubMed Shienbaum G, Gupta OP, Fecarotta C, Patel AH, Kaiser RS, Regillo CD et al (2012) Bevacizumab for neovascular age-related macular degeneration using a treat-and-extend regimen: clinical and economic impact. Am J Ophthalmol 153:468–473CrossRefPubMed
29.
Zurück zum Zitat Copete S, Flores-Moreno I, Montero JA, Duker JS, Ruiz-Moreno JM (2014) Direct comparison of spectral-domain and swept-source OCT in the measurement of choroidal thickness in normal eyes. Br J Ophthalmol 98:334–338CrossRefPubMed Copete S, Flores-Moreno I, Montero JA, Duker JS, Ruiz-Moreno JM (2014) Direct comparison of spectral-domain and swept-source OCT in the measurement of choroidal thickness in normal eyes. Br J Ophthalmol 98:334–338CrossRefPubMed
30.
Zurück zum Zitat Tan CS, Ouyang Y, Ruiz H, Sadda SR (2012) Diurnal variation of choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci 53:261–266CrossRefPubMed Tan CS, Ouyang Y, Ruiz H, Sadda SR (2012) Diurnal variation of choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci 53:261–266CrossRefPubMed
Metadaten
Titel
Comparability of retinal thickness measurements using different scanning protocols on spectral-domain optical coherence tomography
verfasst von
Milton C. Chew
Louis W. Lim
Eujin Tan
Colin S. Tan
Publikationsdatum
18.02.2016
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 6/2016
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-016-0197-4

Weitere Artikel der Ausgabe 6/2016

International Ophthalmology 6/2016 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.